ZA200801276B - Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands - Google Patents
Aminoaryl sulphonamide derivatives as functional 5-HT6 ligandsInfo
- Publication number
- ZA200801276B ZA200801276B ZA200801276A ZA200801276A ZA200801276B ZA 200801276 B ZA200801276 B ZA 200801276B ZA 200801276 A ZA200801276 A ZA 200801276A ZA 200801276 A ZA200801276 A ZA 200801276A ZA 200801276 B ZA200801276 B ZA 200801276B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulphonamide derivatives
- ligands
- functional
- aminoaryl
- aminoaryl sulphonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Semiconductor Integrated Circuits (AREA)
- Insulated Gate Type Field-Effect Transistor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1127CH2005 | 2005-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200801276B true ZA200801276B (en) | 2009-02-25 |
Family
ID=36130030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200801276A ZA200801276B (en) | 2005-08-12 | 2008-02-06 | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7998981B2 (xx) |
| EP (1) | EP1919896B1 (xx) |
| JP (1) | JP5091138B2 (xx) |
| KR (1) | KR101016972B1 (xx) |
| CN (1) | CN101258144B (xx) |
| AT (1) | ATE452885T1 (xx) |
| AU (1) | AU2005335620B2 (xx) |
| BR (1) | BRPI0520579B8 (xx) |
| CA (1) | CA2618636C (xx) |
| CY (1) | CY1110276T1 (xx) |
| DE (1) | DE602005018554D1 (xx) |
| DK (1) | DK1919896T3 (xx) |
| EA (1) | EA013875B1 (xx) |
| ES (1) | ES2337167T3 (xx) |
| HK (1) | HK1116796A1 (xx) |
| MX (1) | MX2008002018A (xx) |
| NO (1) | NO340511B1 (xx) |
| NZ (1) | NZ566495A (xx) |
| PL (1) | PL1919896T3 (xx) |
| PT (1) | PT1919896E (xx) |
| SI (1) | SI1919896T1 (xx) |
| WO (1) | WO2007020652A1 (xx) |
| ZA (1) | ZA200801276B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2114878B1 (en) | 2007-01-08 | 2010-12-15 | Suven Life Sciences Limited | 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
| CA2683124C (en) | 2007-05-03 | 2012-09-25 | Suven Life Sciences Limited | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| JP5236001B2 (ja) * | 2007-10-26 | 2013-07-17 | スヴェン・ライフ・サイエンシズ・リミテッド | アミノアリールスルホンアミド化合物および５−ｈｔ６リガンドとしてのその使用 |
| WO2010032257A1 (en) * | 2008-09-17 | 2010-03-25 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands |
| NZ601284A (en) * | 2010-01-05 | 2014-03-28 | Suven Life Sciences Ltd | Sulfone compounds as 5-ht6 receptor ligands |
| CN102153884B (zh) * | 2011-02-16 | 2013-06-19 | 连云港清泰化工有限公司 | 一种墨水型染料及其制备方法与用途 |
| CN104725295B (zh) | 2013-12-20 | 2019-05-24 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
| SG11201610407QA (en) | 2014-07-08 | 2017-01-27 | Sunshine Lake Pharma Co Ltd | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0184911B1 (ko) * | 1991-11-25 | 1999-05-01 | 알렌 제이. 스피겔 | 인돌유도체 |
| DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| HUP0003073A3 (en) * | 1997-07-11 | 2002-10-28 | Smithkline Beecham Plc | Benzenesulfonamide derivatives, process for producing them and their use as medicines |
| GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| BR0116481A (pt) * | 2000-12-22 | 2004-01-06 | Wyeth Corp | Compostos de heterociclilalquilindol ou azaindol como ligandos de 5-hidroxitriptamina-6 |
| WO2002098878A1 (en) | 2001-02-08 | 2002-12-12 | Memory Pharmaceuticals Corporation | Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| WO2003011284A1 (en) * | 2001-08-03 | 2003-02-13 | Pharmacia & Upjohn Company | 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| JP2005528587A (ja) | 2002-02-01 | 2005-09-22 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 新規ヒト５−ｈｔ６受容体に関連する疾患のための診断用および治療用物質 |
| EP1471912A1 (en) | 2002-02-05 | 2004-11-03 | Glaxo Group Limited | Method of promoting neuronal growth |
| WO2003072548A1 (en) | 2002-02-22 | 2003-09-04 | Pharmacia & Upjohn Company | Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| EP1513809A1 (en) | 2002-06-05 | 2005-03-16 | F. Hoffmann-La Roche Ag | 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| ES2274285T3 (es) | 2002-10-18 | 2007-05-16 | F. Hoffmann-La Roche Ag | 4-piperanzinilbencenosulfonilindoles con afinidad al receptor 5-ht6. |
| KR100776118B1 (ko) | 2002-11-28 | 2007-11-15 | 수벤 라이프 사이언시스 리미티드 | 엔-아릴술포닐-3-아미노알콕시인돌 |
| ES2310243T3 (es) | 2002-11-28 | 2009-01-01 | Suven Life Sciences Limited | Indoles n-aril-3-sulfonil sustituidos que tienen afinidad por receptores de serotonina, proceso para su preparacion y composicion farmaceutica que los contiene. |
| WO2004048331A1 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
| JP4571507B2 (ja) | 2002-12-18 | 2010-10-27 | スベン ライフ サイエンシズ リミティド | セロトニン受容体親和性を有する四環系３−置換インドール |
| EP1663193B1 (en) * | 2003-09-12 | 2012-04-04 | Merck Serono SA | Sulfonamide derivatives for the treatment of diabetes |
-
2005
- 2005-10-26 CN CN2005800515505A patent/CN101258144B/zh not_active Expired - Fee Related
- 2005-10-26 NZ NZ566495A patent/NZ566495A/en not_active IP Right Cessation
- 2005-10-26 DK DK05813800.9T patent/DK1919896T3/da active
- 2005-10-26 EA EA200800573A patent/EA013875B1/ru not_active IP Right Cessation
- 2005-10-26 AT AT05813800T patent/ATE452885T1/de active
- 2005-10-26 EP EP05813800A patent/EP1919896B1/en active Active
- 2005-10-26 JP JP2008525723A patent/JP5091138B2/ja not_active Expired - Fee Related
- 2005-10-26 CA CA2618636A patent/CA2618636C/en not_active Expired - Fee Related
- 2005-10-26 ES ES05813800T patent/ES2337167T3/es active Active
- 2005-10-26 US US11/990,383 patent/US7998981B2/en not_active Expired - Fee Related
- 2005-10-26 SI SI200530928T patent/SI1919896T1/sl unknown
- 2005-10-26 KR KR1020087005968A patent/KR101016972B1/ko active IP Right Grant
- 2005-10-26 WO PCT/IN2005/000345 patent/WO2007020652A1/en active Application Filing
- 2005-10-26 MX MX2008002018A patent/MX2008002018A/es active IP Right Grant
- 2005-10-26 PT PT05813800T patent/PT1919896E/pt unknown
- 2005-10-26 BR BRPI0520579A patent/BRPI0520579B8/pt not_active IP Right Cessation
- 2005-10-26 DE DE602005018554T patent/DE602005018554D1/de active Active
- 2005-10-26 PL PL05813800T patent/PL1919896T3/pl unknown
- 2005-10-26 AU AU2005335620A patent/AU2005335620B2/en not_active Ceased
-
2008
- 2008-02-06 ZA ZA200801276A patent/ZA200801276B/xx unknown
- 2008-02-08 NO NO20080705A patent/NO340511B1/no not_active IP Right Cessation
- 2008-10-15 HK HK08111412.9A patent/HK1116796A1/xx not_active IP Right Cessation
-
2010
- 2010-02-04 CY CY20101100110T patent/CY1110276T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2337167T3 (es) | 2010-04-21 |
| CA2618636C (en) | 2011-01-18 |
| US20100168168A1 (en) | 2010-07-01 |
| ATE452885T1 (de) | 2010-01-15 |
| AU2005335620A1 (en) | 2007-02-22 |
| KR101016972B1 (ko) | 2011-02-25 |
| EP1919896A1 (en) | 2008-05-14 |
| BRPI0520579B8 (pt) | 2021-05-25 |
| SI1919896T1 (sl) | 2010-04-30 |
| NZ566495A (en) | 2010-06-25 |
| MX2008002018A (es) | 2008-03-27 |
| AU2005335620B2 (en) | 2009-12-10 |
| EA200800573A1 (ru) | 2008-08-29 |
| BRPI0520579A2 (pt) | 2009-11-10 |
| CN101258144A (zh) | 2008-09-03 |
| HK1116796A1 (en) | 2009-01-02 |
| EA013875B1 (ru) | 2010-08-30 |
| WO2007020652A1 (en) | 2007-02-22 |
| PL1919896T3 (pl) | 2010-05-31 |
| US7998981B2 (en) | 2011-08-16 |
| CY1110276T1 (el) | 2015-01-14 |
| JP5091138B2 (ja) | 2012-12-05 |
| EP1919896B1 (en) | 2009-12-23 |
| BRPI0520579B1 (pt) | 2019-08-06 |
| KR20080039984A (ko) | 2008-05-07 |
| JP2009504633A (ja) | 2009-02-05 |
| NO340511B1 (no) | 2017-05-02 |
| CA2618636A1 (en) | 2007-02-22 |
| PT1919896E (pt) | 2010-02-26 |
| DE602005018554D1 (de) | 2010-02-04 |
| DK1919896T3 (da) | 2010-04-19 |
| NO20080705L (no) | 2008-05-06 |
| CN101258144B (zh) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1116796A1 (en) | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | |
| PL1888541T3 (pl) | Związki benzo[d]izoksazol-3-iloaminy i ich zastosowanie jako ligandów receptora waniloidowego | |
| MX2009003316A (es) | Derivados de pirazina-2-carboxamida como moduladores receptores de cb2. | |
| TW200740814A (en) | Compounds | |
| PT1877364E (pt) | Derivados fenilacetileno com afinidade para o receptor mglur5 | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
| WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
| MX2010002760A (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. | |
| WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| WO2008059339A3 (en) | Isoquinoline derivatives as vanilloid receptor modulators | |
| EA200870606A1 (ru) | Серосодержащие производные пиразола в качестве избирательных антагонистов рецептора каннабиноидов св | |
| UA94053C2 (ru) | Замещенные производные 3-сульфонилиндазола в качестве лигандов гидрокситриптамина-6 | |
| MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
| DK2155674T3 (da) | Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander | |
| HK1120424A1 (en) | Carbazole derivatives as functional 5-ht6 ligands | |
| MX2008012824A (es) | Derivados de sulfonil-3-heterociclilindazol como ligandos de 5-hidroxitriptamina-6. | |
| UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов |